Clinical Trial Update: Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup

View source ↗

Summary

This clinical trial update describes NCT07441941, evaluating single-fraction pulmonary ablative radiotherapy for oligometastatic lung tumors and non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Oligometastatic Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Oligometastatic Lung Tumor, NSCLC (Non-small Cell Lung Cancer) | Status: RECRUITING